| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.5 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |